A Blog About Intellectual Property Litigation and the District of Delaware


Entries for tag: Hearsay

Patent lawyers often lament their clients' casual correspondence, which sometimes read like the villains monologue that might close the first act of an early 80's Disney Movie.

"Steal? Of course I stole, the work is lucky I left him hands grovel or eyes to cry." AI-Generated, displayed with permission

Today's case, Jackson v. NuVasive, Inc., C.A. No. 21-53-RGA, D.I. 309 (D. Del. Aug. 2, 2024), is the rare case where those casual communications are helpful to the case.

You see, NuVasive had a prior agreement with Dr. Jackson that included a covenant not "assert . . . any claim that the development, manufacture . . . or exploitation of any NuVasive prodect . . . infringes and of the Jackson Group's rights" in a variety of defined IP categories. So, when Dr. Jackson sued for infringement of various patents not specifically listed in the agreement, the parties naturally disputed whether they fell within the terms of the covenant.

This leads us to an internal email from one of NuVasive's IP attorneys who worked on the agreement which helpfully stated, "I just want to ensure we’re as clear as possible that we’re FOREVER FREE FROM JACKSON (and any down-stream licensees/assignees) based on the rights we originally obtained and are now obtaining.”

Plaintiff moved in limine to exclude this email as hearsay, arguing that NuVasive would use it to prove the truth of the statement that they "were obtaining" rights that would leave them "FOREVER FREE" of Jackson.

Judge Andrews, however, found that the statement could be admitted subject to a limiting instruction:

Mr. Spangler's live testimony about what he wanted to achieve in the 2014 Agreement is not hearsay. The email clearly expresses Mr. Spangler's goal in the negotiations, which is evidence of his motive, intent, and plan. See Fed. R. Evid. 803(3). His motive, intent, and plan, in conjunction with other evidence, appear to be relevant to proving two of Defendant's counterclaims . . . I agree with Defendant that if Mr. Spangler's testimony were challenged, as it seems almost certainly likely to be, at least impliedly, the email would not be hearsay if offered in response to that challenge. Fed. R. Evid. 801(d)(l)(B) . . . . Thus, I will admit the email. The motion (D.I. 293) is DENIED. There is a bit of hearsay within the email. If Plaintiff wants me to give a limiting instruction in connection with that bit, Plaintiff is ORDERED to submit any such proposal before the pretrial conference is held.

Id. at 3-4.

I for one find it amusing that this rare example of a communication helpful to a case was authored by an attorney. It's probably good advice to all you in-house folks out there—send the occasional email to your buds explaining that you're totally in the right. It might turn out to be important one day.

"Gather 'round, fellow developers, while I tell you the age-old tale of how we we have an implied license to Sprint's patents." AI-Generated, displayed with permission

Here's one I haven't seen before. In Sprint Communications Company L.P. v. WideOpenWest, Inc., C.A. No. 18-361-RGA (D. Del.), the defendant apparently sought to admit company "folklore" in support of its implied license defense.

The Court found that this "folklore" was relevant to the implied license defense:

While arguing for its second motion in limine (D.I. 433), Plaintiff Sprint raised the issue of certain privileged communications. . . . Plaintiffs second motion in limine sought to exclude testimony about company "folklore" regarding a right to practice Sprint's patents. Defendants plan to assert the affirmative defense of implied license, supported by this "folklore" testimony from ...

AI-generated image of a defendant relying on non-prior art documents as evidence of prior art
AI-generated image of a defendant relying on non-prior art documents as evidence of prior art Andrew E. Russell, displayed with permission

Judge Stark issued an oral order yesterday addressing a motion in limine in Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd., C.A. No. 19-1938-LPS (D. Del.).

According to the briefing, plaintiff sought to exclude two exhibits that were dated after the priority date of the patent.

The first was a 2005 "review article" published just months after the priority date. According to defendants' brief, "does not present original data" and instead "discusses the information known in the art before the priority date."

The second exhibit was published in 2021 and includes a "history of research …